Visit TheBody.com for Patient Education
You are not currently logged in. Login or Register



Sign up for free e-mail/fax newsletters!

Home All Topics Newsroom Conferences JournalView Clinical Management CME/CE Ask Your Colleagues
Saquinavir (Invirase)

Overview | News | Research

See also: Adverse Events of HIV/HAART | Drug Interactions
The Basics
  • A Clinical Overview of Saquinavir (Invirase) (Regularly Updated)
    To read PDF, click here
    From U.S. National Institutes of Health

  • Prescribing Information for Saquinavir (Invirase) (PDF) (July 2007)
    From Roche

  • Drug Interactions: Saquinavir Soft-Gel Capsule (August 2004)
    From Project Inform

  • Drug Interactions: Saquinavir Hard-Gel Capsule (April 2004)
    From Project Inform

News
  • Recent Updates to Invirase Package Insert (June 11, 2008)
    From U.S. Food and Drug Administration

  • Dear Dr. Letter: Fortovase (Saquinavir) Discontinuation Notice (PDF) (May 2005)
    From Roche

  • Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
    To read PDF, click here
    From U.S. Food and Drug Administration

  • New 500-mg Tablet Formulation of Invirase (Saquinavir) Approved (December 17, 2004)
    From U.S. Food and Drug Administration

    BROWSE ALL TOPICS:
  • Clinical Management
  • Clinical Management
    • Clinical Management Home
    • Antiretroviral Therapy
    • Complications of HIV/HAART
    • Research & Development
    • Clinical Trials
    • More ...
  • Conference Coverage
  • Conference Coverage
    • Conference Coverage Home
    • CROI 2008
    • IDSA 2007
    • ICAAC 2007
    • IAS 2007
    • Previous Conferences
    • Upcoming Conferences
    • More ...
  • Epidemiology
  • Epidemiology
    • Epidemiology Home
    • Global Statistics
    • U.S. and Canada
    • Africa
    • Asia
    • Latin America, Caribbean
    • Western Europe
    • More ...
  • Transmission & Basic Science
  • Transmission & Basic Science
    • Transmission Home
    • HIV Pathogensis & Immunology
    • HIV Prevention
    • HIV Testing
    • Other STDs
    • HIV History
    • More ...
  • Professional Development
  • Professional Development
    • Professional Development Home
    • Training Resources
    • Treatment Education
    • News & Analysis
    • More ...
  • Policy & Activism
  • Policy & Activism
    • Policy & Activism Home
    • AIDS Drug Assistance Programs
    • Ryan White CARE Act
    • FDA Drug Review & Approval
    • Resource-Limited Countries
    • More ...

global Toolbox

Contact Us | Privacy Policy

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.